[11 June 2013]
Products Affected - Description
Nimodipine capsules, Caraco
30 mg capsules, 30 count (NDC 57664-0135-64)
30 mg capsules, 100 count (NDC 57664-0135-65)
Nimodipine capsules, Heritage Pharmaceuticals
30 mg capsules, 30 count (NDC 23155-0108-30)
30 mg capsules, 100 count (NDC 23155-0108-00)
Nimodipine capsules, Teva
30 mg capsules, 30 count (NDC 00555-0980-37) - discontinued
30 mg capsules, 100 count (NDC 00555-0980-40) - discontinued
Reason for the Shortage
- Caraco cannot provide a reason for the shortage.
- Teva discontinued nimodipine capsules in early-March, 2013.
There are no presentations readily available.
Estimated Resupply Dates
- Caraco has nimodipine capsules on back order and the company cannot estimate a release date.
- Heritage has nimodipine capsules on allocation.
June 11, 2013; May 14, 2013; May 10, 2013; March 19, 2013; February 22, 2013; January 23, 2013; December 18, 2012; November 20, 2012; November 2, 2012, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins